2 results
Combining anticoagulants and antiplatelets #Management #PrimaryCare #Cardiology #Antiplatelet #DOAC #Anticoagulation #Combination #BMJ
antiplatelets #Management ... #PrimaryCare #Cardiology ... #Antiplatelet #DOAC ... #Anticoagulation ... #Combination #BMJ
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
anticoagulants (DOACs ... weight heparin; BMI ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology